These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2422473)

  • 1. Importance of interaction with adrenergic neurons for antifibrillatory action of bretylium in the dog.
    Frame VB; Wang HH
    J Cardiovasc Pharmacol; 1986; 8(2):336-45. PubMed ID: 2422473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of the effect of bretylium on the ventricular fibrillation threshold in dogs.
    Euler DE; Scanlon PJ
    Am J Cardiol; 1985 May; 55(11):1396-401. PubMed ID: 3993577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The antiarrhythmic and antifibrillatory actions of bretylium and its o-iodobenzyl trimethylammonium analog, UM-360.
    Kniffen FJ; Lomas TE; Counsell RE; Lucchesi BR
    J Pharmacol Exp Ther; 1975 Jan; 192(1):120-8. PubMed ID: 1123718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antifibrillatory action of bretylium: role of the sympathetic nervous system.
    Kopia GA; Lucchesi BR
    Pharmacology; 1987; 34(1):37-47. PubMed ID: 3575413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the adrenergic nerve terminal in digitalis-induced cardiac toxicity: a study of the effects of pharmacological and surgical denervation.
    Lathers CM; Gerard-Ciminera JL; Baskin SI; Krusz JC; Kelliher GJ; Goldberg PB; Roberts J
    J Cardiovasc Pharmacol; 1982; 4(1):91-8. PubMed ID: 6176806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antifibrillatory effects of high dose bretylium and a lidocaine-bretylium combination during cardiopulmonary resuscitation.
    Hanyok JJ; Chow MS; Kluger J; Fieldman A
    Crit Care Med; 1988 Jul; 16(7):691-4. PubMed ID: 3131067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of bretylium and lidocaine on ventricular fibrillation in the isolated rabbit heart.
    Aravindakshan V; Gettes LS
    Cardiovasc Res; 1975 Jan; 9(1):19-28. PubMed ID: 235369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Symposium on the management of ventricular dysrhythmias. Antifibrillatory versus antiectopic therapy.
    Anderson JL
    Am J Cardiol; 1984 Jul; 54(2):7A-13A. PubMed ID: 6147079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bretylium tosylate: a newly available antiarrhythmic drug for ventricular arrhythmias.
    Heissenbuttel RH; Bigger JT
    Ann Intern Med; 1979 Aug; 91(2):229-38. PubMed ID: 380436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The action of reserpine, 6-hydroxydopamine, and bretylium on digitalis-induced cardiotoxicity.
    Lathers CM; Gerard-Ciminera JL; Baskin SI; Krusz JC; Kelliher GJ; Roberts J
    Eur J Pharmacol; 1981 Dec; 76(4):371-9. PubMed ID: 6799304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bretylium tosylate: profile of the only available class III antiarrhythmic agent.
    Anderson JL
    Clin Ther; 1985; 7(2):205-24. PubMed ID: 3886143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antifibrillatory effects of lidocaine and bretylium immediately postcardiopulmonary resuscitation.
    Chow MS; Kluger J; DiPersio DM; Lawrence R; Fieldman A
    Am Heart J; 1985 Nov; 110(5):938-43. PubMed ID: 4061267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amiodarone versus bretylium for suppression of reperfusion arrhythmias in dogs.
    Rosalion A; Snow NJ; Horrigan TP; Noon DL; Mostow ND
    Ann Thorac Surg; 1991 Jan; 51(1):81-5. PubMed ID: 1985582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of bretylium tosylate on ventricular fibrillation threshold during hypothermia in dogs.
    Bjørnstad H; Mortensen E; Sager G; Refsum H
    Am J Emerg Med; 1994 Jul; 12(4):407-12. PubMed ID: 8031422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of presynaptic alpha-adrenoceptor blockade on responses to cardiac nerve stimulation in anesthetized dogs.
    Lokhandwala MF; Buckley JP
    Eur J Pharmacol; 1976 Nov; 40(1):183-6. PubMed ID: 186276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antifibrillatory effects of class III antiarrhythmic drugs: comparative study with flecainide.
    Usui M; Inoue H; Saihara S; Sugimoto T
    J Cardiovasc Pharmacol; 1993 Mar; 21(3):376-83. PubMed ID: 7681497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A method for quantitating antifibrillatory effects of drugs after coronary reperfusion in dogs: improved outcome with bretylium.
    Wenger TL; Lederman S; Starmer CF; Brown T; Strauss HC
    Circulation; 1984 Jan; 69(1):142-8. PubMed ID: 6689638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of bretylium and clofilium on dispersion of refractoriness and vulnerability to ventricular fibrillation in the ischemic feline heart.
    Kowey PR; Friehling TD; O'Connor KM; Wetstein L; Kelliher GJ
    Am Heart J; 1985 Aug; 110(2):363-70. PubMed ID: 4025111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of ventricular fibrillation and positive inotropic action of bethanidine sulfate, a chemical analog of bretylium tosylate that is well absorbed orally.
    Bacaner MB; Hoey MF; Macres MG
    Am J Cardiol; 1982 Jan; 49(1):45-55. PubMed ID: 7053610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of lidocaine and bretylium on energy requirements for transthoracic defibrillation: experimental studies.
    Kerber RE; Pandian NG; Jensen SR; Constantin L; Kieso RA; Melton J; Hunt M
    J Am Coll Cardiol; 1986 Feb; 7(2):397-405. PubMed ID: 3944361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.